Iron and infection in infancy--report on field studies in Papua New Guinea: II. Protocol and description of study cohort.
The protocol for a prospective, randomized, double-blind, placebo controlled trial of iron prophylaxis in infants is described. Specific design points discussed include (i) control and "blind", (ii) dose, preparation and age of administration of iron, (iii) standardization of morbidity recording, (iv) data analysis and (v) ethics. The study cohort at birth is described and rationale for exclusions and reasons for withdrawals are discussed. An initial descriptive comparison is made of treatment and control groups entering the trial at two months of age.
D000367:Age Factors; D000747:Anemia, Hypochromic / Q000453:epidemiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004198:Disease Susceptibility; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D017053:Infection Control; D007239:Infections / Q000453:epidemiology / Q000209:etiology; D000090463:Iron Deficiencies; D007505:Iron-Dextran Complex / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010219:Papua New Guinea; D011446:Prospective Studies
D007505:Iron-Dextran Complex